메뉴 건너뛰기




Volumn 163, Issue 5, 2003, Pages 1887-1899

The Myofibroblast Is the Predominant Plasminogen Activator Inhibitor-1-Expressing Cell Type in Human Breast Carcinomas

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANTIBODY; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0142182099     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63547-X     Document Type: Article
Times cited : (70)

References (62)
  • 2
    • 0027535914 scopus 로고
    • Biology and biochemistry of proteinases in tumor invasion
    • Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-195
    • (1993) Physiol Rev , vol.73 , pp. 161-195
    • Mignatti, P.1    Rifkin, D.B.2
  • 3
    • 0033981473 scopus 로고    scopus 로고
    • The plasminogen activation system in tumor growth, invasion, and metastasis
    • Andreasen PA, Egelund R, Petersen HH: The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000, 57:25-40
    • (2000) Cell Mol Life Sci , vol.57 , pp. 25-40
    • Andreasen, P.A.1    Egelund, R.2    Petersen, H.H.3
  • 4
    • 0030788411 scopus 로고    scopus 로고
    • The urokinase-type plasminogen activator system in cancer metastasis: A review
    • Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997, 72:1-22
    • (1997) Int J Cancer , vol.72 , pp. 1-22
    • Andreasen, P.A.1    Kjoller, L.2    Christensen, L.3    Duffy, M.J.4
  • 6
    • 0031470554 scopus 로고    scopus 로고
    • Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
    • Chen ZL, Strickland S: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997, 91:917-925
    • (1997) Cell , vol.91 , pp. 917-925
    • Chen, Z.L.1    Strickland, S.2
  • 9
    • 0036005954 scopus 로고    scopus 로고
    • The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor-1: Roles of the reactive centre loop, the shutter region, the flexible joint region, and the small serpin fragment
    • Wind T, Hansen M, Jensen JK, Andreasen P: The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor-1: roles of the reactive centre loop, the shutter region, the flexible joint region, and the small serpin fragment. Biol Chem 2002, 383:21-36
    • (2002) Biol Chem , vol.383 , pp. 21-36
    • Wind, T.1    Hansen, M.2    Jensen, J.K.3    Andreasen, P.4
  • 11
    • 0025995880 scopus 로고
    • Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer
    • Janicke F, Schmitt M, Graeff H: Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin Thromb Hemost 1991, 17:303-312
    • (1991) Semin Thromb Hemost , vol.17 , pp. 303-312
    • Janicke, F.1    Schmitt, M.2    Graeff, H.3
  • 13
    • 0027223048 scopus 로고
    • High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
    • Grondahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Dano K, Blichert-Toft M: High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993, 53:2513-2521
    • (1993) Cancer Res , vol.53 , pp. 2513-2521
    • Grondahl-Hansen, J.1    Christensen, I.J.2    Rosenquist, C.3    Brunner, N.4    Mouridsen, H.T.5    Dano, K.6    Blichert-Toft, M.7
  • 15
    • 0036329424 scopus 로고    scopus 로고
    • Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: From pilot to level 1 evidence studies
    • Duffy MJ: Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem 2002, 48:1194-1197
    • (2002) Clin Chem , vol.48 , pp. 1194-1197
    • Duffy, M.J.1
  • 17
    • 0036695216 scopus 로고    scopus 로고
    • Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts
    • Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Janicke F, Thomssen C: Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts. Clin Breast Cancer 2002, 3:196-200
    • (2002) Clin Breast Cancer , vol.3 , pp. 196-200
    • Harbeck, N.1    Schmitt, M.2    Kates, R.E.3    Kiechle, M.4    Zemzoum, I.5    Janicke, F.6    Thomssen, C.7
  • 18
    • 0030815119 scopus 로고    scopus 로고
    • Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model
    • Ma D, Gerard RD, Li XY, Alizadeh H, Niederkorn JY: Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model Blood 1997, 90:2738-2746
    • (1997) Blood , vol.90 , pp. 2738-2746
    • Ma, D.1    Gerard, R.D.2    Li, X.Y.3    Alizadeh, H.4    Niederkorn, J.Y.5
  • 19
    • 0028821827 scopus 로고
    • Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model
    • Soff GA, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S, Kwaan HC: Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model. J Clin Invest 1995, 96:2593-2600
    • (1995) J Clin Invest , vol.96 , pp. 2593-2600
    • Soff, G.A.1    Sanderowitz, J.2    Gately, S.3    Verrusio, E.4    Weiss, I.5    Brem, S.6    Kwaan, H.C.7
  • 20
    • 0037146737 scopus 로고    scopus 로고
    • Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis
    • Praus M, Collen D, Gerard RD: Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int J Cancer 2002, 102:584-591
    • (2002) Int J Cancer , vol.102 , pp. 584-591
    • Praus, M.1    Collen, D.2    Gerard, R.D.3
  • 21
    • 0031056819 scopus 로고    scopus 로고
    • Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice
    • Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R: Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice [published erratum appears in Cancer Res 1998 Jan 1;58(1):179]. Cancer Res 1997, 57:559-563
    • (1997) Cancer Res , vol.57 , pp. 559-563
    • Jankun, J.1    Keck, R.W.2    Skrzypczak-Jankun, E.3    Swiercz, R.4
  • 22
    • 0031974509 scopus 로고    scopus 로고
    • published erratum appears Jan 1
    • Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R: Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice [published erratum appears in Cancer Res 1998 Jan 1;58(1):179]. Cancer Res 1997, 57:559-563
    • (1998) Cancer Res , vol.58 , Issue.1 , pp. 179
  • 24
    • 0029956043 scopus 로고    scopus 로고
    • Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma
    • Eitzman DT, Krauss JC, Shen T, Cui J, Ginsburg: Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Blood 1996, 87:4718-4722
    • (1996) Blood , vol.87 , pp. 4718-4722
    • Eitzman, D.T.1    Krauss, J.C.2    Shen, T.3    Cui, J.4    Ginsburg5
  • 27
    • 0042804870 scopus 로고    scopus 로고
    • Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene deficient mice
    • Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K, Johnsen M: Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene deficient mice. Oncogene 2003, 22:4389-4397
    • (2003) Oncogene , vol.22 , pp. 4389-4397
    • Almholt, K.1    Nielsen, B.S.2    Frandsen, T.L.3    Brunner, N.4    Dano, K.5    Johnsen, M.6
  • 30
    • 0025785994 scopus 로고
    • Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: Possible roles in tumor progression and metastasis
    • Sumiyoshi K, Baba S, Sakaguchi S, Urano T, Takada Y, Takada A: Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb Res 1991, 63:59-71
    • (1991) Thromb Res , vol.63 , pp. 59-71
    • Sumiyoshi, K.1    Baba, S.2    Sakaguchi, S.3    Urano, T.4    Takada, Y.5    Takada, A.6
  • 31
    • 0027361935 scopus 로고
    • Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
    • Jankun J, Merrick HW, Goldblatt PJ: Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 1993, 53:135-144
    • (1993) J Cell Biochem , vol.53 , pp. 135-144
    • Jankun, J.1    Merrick, H.W.2    Goldblatt, P.J.3
  • 32
    • 0028959504 scopus 로고
    • Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
    • Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, Smith HS: Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer 1995, 60:597-603
    • (1995) Int J Cancer , vol.60 , pp. 597-603
    • Bianchi, E.1    Cohen, R.L.2    Dai, A.3    Thor, A.T.4    Shuman, M.A.5    Smith, H.S.6
  • 33
    • 0029992385 scopus 로고    scopus 로고
    • Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas
    • Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA: Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas. Int J Cancer 1996, 66:441-452
    • (1996) Int J Cancer , vol.66 , pp. 441-452
    • Christensen, L.1    Wiborg Simonsen, A.C.2    Heegaard, C.W.3    Moestrup, S.K.4    Andersen, J.A.5    Andreasen, P.A.6
  • 34
    • 0029968743 scopus 로고    scopus 로고
    • Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
    • Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG: Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 1996, 77:1079-1088
    • (1996) Cancer , vol.77 , pp. 1079-1088
    • Costantini, V.1    Sidoni, A.2    Deveglia, R.3    Cazzato, O.A.4    Bellezza, G.5    Ferri, I.6    Bucciarelli, E.7    Nenci, G.G.8
  • 35
    • 0030703165 scopus 로고    scopus 로고
    • Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues
    • Umeda T, Eguchi Y, Okino K, Kodama M, Hattori T: Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J Pathol 1997, 183:88-397
    • (1997) J Pathol , vol.183 , pp. 88-397
    • Umeda, T.1    Eguchi, Y.2    Okino, K.3    Kodama, M.4    Hattori, T.5
  • 37
    • 0033820073 scopus 로고    scopus 로고
    • Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: Fibroblastic expression has strong associations with tumor pathology
    • Dublin E, Hanby A, Patel NK, Liebman R, Barnes D: Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: fibroblastic expression has strong associations with tumor pathology. Am J Pathol 2000, 157:1219-1227
    • (2000) Am J Pathol , vol.157 , pp. 1219-1227
    • Dublin, E.1    Hanby, A.2    Patel, N.K.3    Liebman, R.4    Barnes, D.5
  • 38
    • 0036360538 scopus 로고    scopus 로고
    • Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast
    • Zhao H, Morimoto T, Sasa M, Tanaka T, Izumi K: Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. Breast Cancer 2002, 9:118-126
    • (2002) Breast Cancer , vol.9 , pp. 118-126
    • Zhao, H.1    Morimoto, T.2    Sasa, M.3    Tanaka, T.4    Izumi, K.5
  • 39
    • 0031962017 scopus 로고    scopus 로고
    • Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor
    • Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA: Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Biochem J 1998, 329:55-63
    • (1998) Biochem J , vol.329 , pp. 55-63
    • Rodenburg, K.W.1    Kjoller, L.2    Petersen, H.H.3    Andreasen, P.A.4
  • 40
    • 0037134909 scopus 로고    scopus 로고
    • The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand
    • Jensen JK, Wind T, Andreasen PA: The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand. FEBS Lett 2002, 521:91-94
    • (2002) FEBS Lett , vol.521 , pp. 91-94
    • Jensen, J.K.1    Wind, T.2    Andreasen, P.A.3
  • 41
    • 0026333459 scopus 로고
    • Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies
    • Munch M, Heegaard C, Jensen PH, Andreasen PA: Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies. FEBS Lett 1991, 295:102-106
    • (1991) FEBS Lett , vol.295 , pp. 102-106
    • Munch, M.1    Heegaard, C.2    Jensen, P.H.3    Andreasen, P.A.4
  • 42
    • 0020352040 scopus 로고
    • Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody
    • Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoft K, Zeuthen J, Dano K: Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 1982, 21:6410-6415
    • (1982) Biochemistry , vol.21 , pp. 6410-6415
    • Nielsen, L.S.1    Hansen, J.G.2    Skriver, L.3    Wilson, E.L.4    Kaltoft, K.5    Zeuthen, J.6    Dano, K.7
  • 43
    • 0031897322 scopus 로고    scopus 로고
    • Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques
    • Ferrier CM, van Geloof WL, de Witte HH, Kramer MD, Ruiter DJ, van Muijen GN: Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. J Histochem Cytochem 1998, 46:469-476
    • (1998) J Histochem Cytochem , vol.46 , pp. 469-476
    • Ferrier, C.M.1    Van Geloof, W.L.2    De Witte, H.H.3    Kramer, M.D.4    Ruiter, D.J.5    Van Muijen, G.N.6
  • 44
    • 0033665746 scopus 로고    scopus 로고
    • Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies
    • Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, Teisner B: Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 2000, 21:754-762
    • (2000) Placenta , vol.21 , pp. 754-762
    • Floridon, C.1    Nielsen, O.2    Holund, B.3    Sweep, F.4    Sunde, L.5    Thomsen, S.G.6    Teisner, B.7
  • 45
    • 0018182699 scopus 로고
    • A better cell line for making hybridomas secreting specific antibodies
    • Shulman M, Wilde CD, Kohler G: A better cell line for making hybridomas secreting specific antibodies. Nature 1978, 276:269-270
    • (1978) Nature , vol.276 , pp. 269-270
    • Shulman, M.1    Wilde, C.D.2    Kohler, G.3
  • 46
    • 0026377425 scopus 로고
    • The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma
    • Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K: The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991, 51:4067-4071
    • (1991) Cancer Res , vol.51 , pp. 4067-4071
    • Pyke, C.1    Kristensen, P.2    Ralfkiaer, E.3    Eriksen, J.4    Dano, K.5
  • 47
    • 0035476863 scopus 로고    scopus 로고
    • Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas
    • Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, Dano K, Lopez-Otin C: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001, 61:7091-7100
    • (2001) Cancer Res , vol.61 , pp. 7091-7100
    • Nielsen, B.S.1    Rank, F.2    Lopez, J.M.3    Balbin, M.4    Vizoso, F.5    Lund, L.R.6    Dano, K.7    Lopez-Otin, C.8
  • 48
    • 0022881517 scopus 로고
    • A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation
    • Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986, 103:2787-2796
    • (1986) J Cell Biol , vol.103 , pp. 2787-2796
    • Skalli, O.1    Ropraz, P.2    Trzeciak, A.3    Benzonana, G.4    Gillessen, D.5    Gabbiani, G.6
  • 49
    • 0023939143 scopus 로고
    • Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues
    • Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G: Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988, 41:707-712
    • (1988) Int J Cancer , vol.41 , pp. 707-712
    • Sappino, A.P.1    Skalli, O.2    Jackson, B.3    Schurch, W.4    Gabbiani, G.5
  • 51
    • 0023706144 scopus 로고
    • Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer
    • Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovsky SM, Bannikov GA: Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 1988, 42:147-153
    • (1988) Int J Cancer , vol.42 , pp. 147-153
    • Guelstein, V.I.1    Tchypysheva, T.A.2    Ermilova, V.D.3    Litvinova, L.V.4    Troyanovsky, S.M.5    Bannikov, G.A.6
  • 53
  • 54
    • 0028890174 scopus 로고
    • The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells
    • Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ: The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995, 95:859-873
    • (1995) J Clin Invest , vol.95 , pp. 859-873
    • Ronnov-Jessen, L.1    Petersen, O.W.2    Koteliansky, V.E.3    Bissell, M.J.4
  • 55
    • 0030061754 scopus 로고    scopus 로고
    • Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
    • Nielsen BS, Sehested M, Timshel S, Pyke C, Dano K: Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest 1996, 74:168-177
    • (1996) Lab Invest , vol.74 , pp. 168-177
    • Nielsen, B.S.1    Sehested, M.2    Timshel, S.3    Pyke, C.4    Dano, K.5
  • 56
    • 0035863308 scopus 로고    scopus 로고
    • Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model
    • Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brunner N: Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res 2001, 61:532-537
    • (2001) Cancer Res , vol.61 , pp. 532-537
    • Frandsen, T.L.1    Holst-Hansen, C.2    Nielsen, B.S.3    Christensen, I.J.4    Nyengaard, J.R.5    Carmeliet, P.6    Brunner, N.7
  • 57
    • 0036005960 scopus 로고    scopus 로고
    • Role of myofibroblasts at the invasion front
    • De Wever O, Mareel M: Role of myofibroblasts at the invasion front. Biol Chem 2002, 383:55-67
    • (2002) Biol Chem , vol.383 , pp. 55-67
    • De Wever, O.1    Mareel, M.2
  • 58
    • 0036512208 scopus 로고    scopus 로고
    • New functions for the matrix metalloproteinases in cancer progression
    • Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174
    • (2002) Nat Rev Cancer , vol.2 , pp. 161-174
    • Egeblad, M.1    Werb, Z.2
  • 59
    • 0030051051 scopus 로고    scopus 로고
    • Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
    • Ronnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996, 76:69-125
    • (1996) Physiol Rev , vol.76 , pp. 69-125
    • Ronnov-Jessen, L.1    Petersen, O.W.2    Bissell, M.J.3
  • 61
    • 0034665101 scopus 로고    scopus 로고
    • Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma
    • Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK: Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol 2000, 165:3154-3161
    • (2000) J Immunol , vol.165 , pp. 3154-3161
    • Cho, S.H.1    Tam, S.W.2    Demissie-Sanders, S.3    Filler, S.A.4    Oh, C.K.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.